The new indication adds to the 2021 approval of Susvimo (ranibizumab) for 'wet' or neovascular age-related macular ...

Seven months after the FDA signed off on a reintroduction of Roche’s eye implant Susvimo, the U.S. regulator has broadened ...

Watch skilled mechanics in action as they replace the diesel valve stem seals of a Nissan truck with precision and expertise.

Brice Williams made jumper to seal the Nebraska Cornhuskers' 80-74 win over the Illinois Fighting Illini. Posted: January 31, ...

When it comes to the potential of H5N1 avian flu, otherwise known as bird flu, picking up mutations that may lead to human-to ...

The FDA regulates what can and can't be called a hearing aid, but that doesn't mean your Samsung Galaxy Buds won't work as a ...

Specific details of the lawsuit are not yet available as the complaint remains under seal at Delaware Court ... Zurzuvae (zuranolone), which is FDA-approved for post-partum depression (PPD).

Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator Instructions) Please note that this conference call is being ...

The FDA’s approval for expanded use reinforces LP-310’s potential as a new therapeutic option for OLP and supports ongoing clinical development efforts.

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class non-opioid analgesic to treat acute pain in adults. “Today’s approval ...